SRTS News and Press, Sensus Healthcare Inc. From 02/08/24

Fourth quarter revenues of $12.6 million up three-fold sequentially, reflect ongoing customer adjustment to macroeconomic conditions Introduces recurring revenue model for the SRT-100 Vision ™ (IG-SRT) to address dermatologist demand Conference c...

2024-02-08 09:16:58 ET More on Sensus Healthcare Sensus Healthcare Q4 2023 Earnings Preview Sensus Healthcare stock jumps on upbeat Q4, FY revenue outlook Seeking Alpha’s Quant Rating on Sensus Healthcare Historical earnings data for Sensus Healthcare ...

BOCA RATON, Fla., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS ), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that the U.S. Patent a...

Turnstone Biologics Corp. (TSBX) is expected to report $-0.73 for Q4 2023 Exro Technologies Inc (EXROF) is expected to report for Q4 2023 Boyd Gaming Corporation (BYD) is expected to report $1.43 for Q4 2023 Onto Innovation Inc. (ONTO) is expected to report $0.99 for Q4 2023 Motor...

Physician-run radiation oncology innovator also to research new indications and broaden the market for SRT to include inflammatory diseases BOCA RATON, Fla., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS ), a medical device company specializing in highly effect...

BOCA RATON, Fla., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS ), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that Samuel O’...

BOCA RATON, Fla. , Jan. 30, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursda...

Sensus Healthcare, Inc. (NASDAQ: SRTS) is one of today's top gainers. The company's shares have moved 2.74% on the day to $2.25. Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial r...

2024-01-23 09:12:48 ET More on Sensus Healthcare Sensus Healthcare, Inc. (SRTS) Q3 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Sensus Healthcare Historical earnings data for Sensus Healthcare Financial information for Sensus Healthcar...

Ships more than 60 SRT units in 2023 To report full financial results and hold conference call on February 8 th BOCA RATON, Fla. , Jan. 23, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS ), a medical device company specializing in highly effective, non-inva...